•60:40 Marketing to Business Development ratio for role requirements. •Possess experience in managing Consumer Healthcare products or equivalent branding/selling activities. • Well versed with interpreting pharmaceutical terms and jargons in order
As the leader of the Strategy team, you are responsible for establishing the long term strategic direction of the Ashtronix Business Intelligence, in partnership with the Ashtronix Business Intelligence management executives.
Our client is one of Asia’s leading digital technology company with a strong global presence. They are at the forefront of delivering Digitalization Platform as-a-Service (DPaaS) via innovative digital solutions.
Business Development Manager that is capable in revenue generation through sales and marketing happenings. The candidate must be able to successfully manage, prioritize and close searches against a timeline.
We are looking for an ambitious and energetic Business Development Manager to help us expand our clientele. The potential clientele of the products includes, but is not limited to,individual doctors, Hospitals/Clinics, Old Age Homes.
The Talent Acquisition Lead (Manager) must come with a strong 360 degree recruiter work experience of at least 5-7 years and is to manage a team and serve as the lead point of contact for all customer account management matters.
Duties: Coordinate, including being able to perform, activities across the various accounting functions: accounts payable, accounts receivable, payroll, cash and treasury management and general accounting
1.Operation Management of Account Sales Section 2.Supply and Demand Mgmt of the company's products in domestic market & regions 3.Marketing Strategy Management 4.Client relationship management 5.Complaint Management
The Senior Executive, Business Development ensures the growing needs of the existing clients are met, continuous engagement of new clients and a sustainable and efficient back-end process is maintained at its optimal professional standards.
To manage and maximise potential recovery from Danaharta’s residual Non-Performing Loan ( NPL) portfolio currently housed under PDNB and/or PAMSB, as well as any other NPLs which may be acquired in the future and to facilitate closure of old NPL ac